Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sica

Showing results (71-80 of 3,027) with videos related to

Pageof 303
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|April 29, 2005
Calcium channel blocker class heterogeneity: select aspects of pharmacokinetics and pharmacodynamicsDomenic A Sica
Current Heart Failure Reports|July 23, 2005
The risks and benefits of aldosterone antagonistsDomenic A Sica
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|June 30, 2005
Novel combinations in the treatment of hypertensionD A Sica
The American Journal of Cardiology|October 7, 2006
Design of a novel controlled-release formulation of carvedilol: pharmacology and clinical aspects. IntroductionDomenic A Sica
Hypertension (Dallas, Tex. : 1979)|July 30, 2014
Urinary potassium excretion: can it predict the onset of hypertension?Domenic A Sica
Seminars in Nephrology|July 14, 2014
Aldosterone and volume management in hypertensive heart diseaseDomenic A Sica
Primary Care|March 1, 1986
Dermatologic emergenciesP A Sica
Radiology|December 3, 2009
Can focused US with a diagnostic US contrast agent favorably affect renal function?Domenic A Sica
Radiology|April 8, 1998
MR imaging for assessment of gastric motility disorders: has its time come?G T Sica
Current Hypertension Reports|July 8, 2003
Renal handling of angiotensin receptor blockers: clinical relevanceDomenic A Sica
Pageof 303

Showing results (71-80 of 3,027) with videos related to

Sort By:
Pageof 303
Journal of Clinical Hypertension (Greenwich, Conn.)|April 29, 2005
Calcium channel blocker class heterogeneity: select aspects of pharmacokinetics and pharmacodynamicsDomenic A Sica
Current Heart Failure Reports|July 23, 2005
The risks and benefits of aldosterone antagonistsDomenic A Sica
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|June 30, 2005
Novel combinations in the treatment of hypertensionD A Sica
The American Journal of Cardiology|October 7, 2006
Design of a novel controlled-release formulation of carvedilol: pharmacology and clinical aspects. IntroductionDomenic A Sica
Hypertension (Dallas, Tex. : 1979)|July 30, 2014
Urinary potassium excretion: can it predict the onset of hypertension?Domenic A Sica
Seminars in Nephrology|July 14, 2014
Aldosterone and volume management in hypertensive heart diseaseDomenic A Sica
Primary Care|March 1, 1986
Dermatologic emergenciesP A Sica
Radiology|December 3, 2009
Can focused US with a diagnostic US contrast agent favorably affect renal function?Domenic A Sica
Radiology|April 8, 1998
MR imaging for assessment of gastric motility disorders: has its time come?G T Sica
Current Hypertension Reports|July 8, 2003
Renal handling of angiotensin receptor blockers: clinical relevanceDomenic A Sica
Pageof 303